Can Buspirone Be Increased from 5mg TID?
Yes, buspirone 5mg TID (15mg/day total) can and should be increased, as the current dose is below the therapeutic range and the patient continues to have anxiety symptoms.
Dosing Algorithm
The FDA-approved therapeutic range for buspirone in generalized anxiety disorder is 15-60 mg/day, with most patients requiring 20-30 mg/day for optimal anxiolytic effect 11. Your patient is currently at the absolute minimum dose (15mg/day total).
Recommended Titration Strategy:
Increase to 10mg TID (30mg/day total) using the following approach:
- Increase by 5mg increments (e.g., increase one dose at a time: 10mg-5mg-5mg, then 10mg-10mg-5mg, then 10mg-10mg-10mg)
- Wait 3-7 days between increases to assess tolerability
- Maximum dose: 60mg/day (20mg TID), though most patients respond at 30mg/day 11
Research supports that buspirone 30mg/day is the standard effective dose, with studies demonstrating significant anxiety reduction at this level 23. The 15mg/day your patient is currently receiving is essentially a starting dose.
Key Clinical Considerations
Onset of action: Buspirone requires 2-4 weeks at therapeutic doses to achieve full anxiolytic effect. If the patient has only been on 5mg TID for a short period, they may not have given adequate time for response even at this subtherapeutic dose.
Dosing convenience: Consider switching to 15mg BID (twice daily) once you reach 30mg/day total. Studies show equivalent efficacy and safety between BID and TID regimens, with BID potentially improving adherence 43.
Safety Profile
Buspirone is generally well-tolerated. The most common side effects at therapeutic doses include:
These are typically mild and dose-dependent. Starting from 15mg/day and titrating gradually minimizes adverse effects 11.
Important Drug Interactions to Screen
Before increasing, verify the patient is NOT taking:
- CYP3A4 inhibitors (erythromycin, itraconazole, grapefruit juice, nefazodone, diltiazem, verapamil) - these can increase buspirone levels 5-20 fold, requiring dose reduction to 2.5mg daily 11
- MAOIs - contraindicated due to serotonin syndrome risk 5
When to Consider Alternatives
If the patient fails to respond after reaching 30-45mg/day for 4 weeks at therapeutic dose, consider:
- Switching to an SSRI (first-line for anxiety disorders in most guidelines)
- Adding CBT (combination therapy superior to monotherapy) 55
- Re-evaluating the diagnosis
The current dose is simply too low to expect therapeutic benefit in most patients with generalized anxiety disorder.